Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Haohai Biological: Wholly owned subsidiary's multi-focus aspheric intraocular lens products receive registration certificates
Haohai Biological announces that its wholly-owned subsidiary, Henan Universe Artificial Lens Research Co., Ltd., recently received the “Medical Device Registration Certificate of the People’s Republic of China” for the multifocal aspheric artificial lens product issued by the National Medical Products Administration. This product is suitable for vision correction in adult cataract patients without a lens, aiming to improve near, intermediate, and distance vision and reduce dependence on glasses. This product is the world’s first approved multifocal artificial lens based on patented Fourier harmonic five-focus diffraction technology, which enables more efficient light energy distribution, improves light energy utilization, and enhances the intermediate vision of traditional trifocal artificial lenses, making vision in the far-mid, mid-range, and near-range areas more continuous and smooth.